Abstract
The recent publication of X-ray structures of SERT includes structures with the potent antidepressant S-Citalopram (S-Cit). Earlier predictions of ligand binding at both a primary (S1) and an allosteric modulator site (S2), were confirmed. We provide herein examples of a series of Citalopram analogs, showing distinct structure-activity relationship (SAR) at both sites that is independent of the SAR at the other site. Analogs with a higher affinity and selectivity than benchmark R-Citalopram (R-Cit) for the S2 versus the S1 site were identified. We deploy structural and computational analyses to explain this SAR and demonstrate the potential utility of the newly emerging X-ray structures within the neurotransmitter:sodium Symporter family for drug design.
Original language | English |
---|---|
Journal | Bioorganic & Medicinal Chemistry Letters |
Volume | 27 |
Issue number | 3 |
Pages (from-to) | 470-478 |
Number of pages | 9 |
ISSN | 0960-894X |
DOIs | |
Publication status | Published - 1 Feb 2017 |